In conclusion, combination of chemotherapeutic gemcitabine and immune vaccination with DCs efficiently removed the lymphoma induced accumulation of MDSCs, and synergistically induced the IFNr production and activation of NK cells and CD8+ T cells, and thus enhanced anti-tumor immunity and improved the survival of the lymphoma bearing mice. This evidence concerns the gene IFNAR2 and neoplasm.